-
1
-
-
0037432067
-
Slowing Parkinson's disease progression: Recent dopamine agonist trials
-
Ahlskog J.E. Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology. 60:2003;381-389
-
(2003)
Neurology
, vol.60
, pp. 381-389
-
-
Ahlskog, J.E.1
-
2
-
-
0037432040
-
Initial agonist treatment of Parkinson disease: A critique
-
Albin R.L., Frey K.A. Initial agonist treatment of Parkinson disease: a critique. Neurology. 60:2003;390-394
-
(2003)
Neurology
, vol.60
, pp. 390-394
-
-
Albin, R.L.1
Frey, K.A.2
-
3
-
-
0032465989
-
Acute regulation of norepinephrine transport: I. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells
-
Apparsundaram S., Galli A., DeFelice L.J., Hartzell H.C., Blakely R.D. Acute regulation of norepinephrine transport: I. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287:1998;733-743
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.287
, pp. 733-743
-
-
Apparsundaram, S.1
Galli, A.2
Defelice, L.J.3
Hartzell, H.C.4
Blakely, R.D.5
-
4
-
-
0034949975
-
Dopamine transporter in vitro binding and in vivo imaging in the brain
-
Bergstrom K.A., Tupala E., Tiihonen J. Dopamine transporter in vitro binding and in vivo imaging in the brain. Pharmacol. Toxicol. 88:2001;287-293
-
(2001)
Pharmacol. Toxicol.
, vol.88
, pp. 287-293
-
-
Bergstrom, K.A.1
Tupala, E.2
Tiihonen, J.3
-
5
-
-
0025615903
-
Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain
-
Dewey S.L., Brodie J.D., Fowler J.S., MacGregor R.R., Schlyer D.J., King P.T., Alexoff D.L., Volkow N.D., Shiue C.Y., Wolf A.P. Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain. Synapse. 6:1990;321-327
-
(1990)
Synapse
, vol.6
, pp. 321-327
-
-
Dewey, S.L.1
Brodie, J.D.2
Fowler, J.S.3
MacGregor, R.R.4
Schlyer, D.J.5
King, P.T.6
Alexoff, D.L.7
Volkow, N.D.8
Shiue, C.Y.9
Wolf, A.P.10
-
6
-
-
0030511826
-
Presynaptic monoamine vesicles in Parkinson's disease and normal aging
-
Frey K.A., Koeppe R.A., Kilbourn M.R., Vander Borght T.M., Albin R.L., Gilman S., Kuhl D.E. Presynaptic monoamine vesicles in Parkinson's disease and normal aging. Ann. Neurol. 140:1996;873-884
-
(1996)
Ann. Neurol.
, vol.140
, pp. 873-884
-
-
Frey, K.A.1
Koeppe, R.A.2
Kilbourn, M.R.3
Vander Borght, T.M.4
Albin, R.L.5
Gilman, S.6
Kuhl, D.E.7
-
7
-
-
0035849532
-
Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD
-
Guttman M., Stewart D., Hussey D., Wilson A., Houle S., Kish S. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology. 56:2001;1559-1564
-
(2001)
Neurology
, vol.56
, pp. 1559-1564
-
-
Guttman, M.1
Stewart, D.2
Hussey, D.3
Wilson, A.4
Houle, S.5
Kish, S.6
-
8
-
-
0036459950
-
Protein kinase-C mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells
-
Hoji-Kasai Y., Itakura M., Kataoka M., Yamamori S., Takahashi M. Protein kinase-C mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Eur. J. Neurosci. 15:2002;1390-1394
-
(2002)
Eur. J. Neurosci.
, vol.15
, pp. 1390-1394
-
-
Hoji-Kasai, Y.1
Itakura, M.2
Kataoka, M.3
Yamamori, S.4
Takahashi, M.5
-
9
-
-
0041886880
-
Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: Comparison of L-DOPA and pramipexole
-
Kemmerer E.S., Desmond T.J., Albin R.L., Kilbourn M.R., Frey K.A. Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Exp. Neurol. 183:2003;81-86
-
(2003)
Exp. Neurol.
, vol.183
, pp. 81-86
-
-
Kemmerer, E.S.1
Desmond, T.J.2
Albin, R.L.3
Kilbourn, M.R.4
Frey, K.A.5
-
10
-
-
3042578809
-
Long-term reproducibility of in vivo measures of radioligand binding
-
(in press)
-
Kilbourn M.R. Long-term reproducibility of in vivo measures of radioligand binding. Nucl. Med. Biol. 2004;. (in press)
-
(2004)
Nucl. Med. Biol.
-
-
Kilbourn, M.R.1
-
11
-
-
0030152867
-
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters
-
Kilbourn M.R., Frey K.A., Vander Borght T., Sherman P.S. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl. Med. Biol. 23:1996;467-471
-
(1996)
Nucl. Med. Biol.
, vol.23
, pp. 467-471
-
-
Kilbourn, M.R.1
Frey, K.A.2
Vander Borght, T.3
Sherman, P.S.4
-
12
-
-
0036497874
-
In vivo measures of dopaminergic radioligands in the rat brain: Equilibrium infusion studies
-
Kilbourn M.R., Sherman P.S., Kuszpit K. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies. Synapse. 43:2002;188-194
-
(2002)
Synapse
, vol.43
, pp. 188-194
-
-
Kilbourn, M.R.1
Sherman, P.S.2
Kuszpit, K.3
-
13
-
-
18844471416
-
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
-
Lee C.S., Samii A., Sossi V., Ruth T.J., Schulzer M., Holden J.E., Wudel J., Pal P.K., de la Fuente-Fernandez R., Calne D.B., Stoessl A.J. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann. Neurol. 47:2000;493-503
-
(2000)
Ann. Neurol.
, vol.47
, pp. 493-503
-
-
Lee, C.S.1
Samii, A.2
Sossi, V.3
Ruth, T.J.4
Schulzer, M.5
Holden, J.E.6
Wudel, J.7
Pal, P.K.8
De La Fuente-Fernandez, R.9
Calne, D.B.10
Stoessl, A.J.11
-
14
-
-
0037820586
-
The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines
-
Loder M.K., Melikian H.E. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278:2003;22168-22174
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 22168-22174
-
-
Loder, M.K.1
Melikian, H.E.2
-
15
-
-
0037008254
-
Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine
-
Riddle E.L., Topham M.K., Haycock J.W., Hanson G.R., Fleckenstein A.E. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur. J. Pharmacol. 449:2002;71-74
-
(2002)
Eur. J. Pharmacol.
, vol.449
, pp. 71-74
-
-
Riddle, E.L.1
Topham, M.K.2
Haycock, J.W.3
Hanson, G.R.4
Fleckenstein, A.E.5
-
16
-
-
0036812515
-
Methylphenidate redistributes vesicular monoamine transporter-2: Role of dopamine receptors
-
Sandoval V., Riddle E.L., Hanson G.R., Fleckenstein A.E. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J. Neurosci. 22:2002;8705-8710
-
(2002)
J. Neurosci.
, vol.22
, pp. 8705-8710
-
-
Sandoval, V.1
Riddle, E.L.2
Hanson, G.R.3
Fleckenstein, A.E.4
-
18
-
-
0042190152
-
Agonizing over dopaminergic replacement therapy - Lessons from animal models of Parkinson's disease
-
Stoessl A.J. Agonizing over dopaminergic replacement therapy - Lessons from animal models of Parkinson's disease. Exp. Neurol. 183:2003;1-3
-
(2003)
Exp. Neurol.
, vol.183
, pp. 1-3
-
-
Stoessl, A.J.1
-
19
-
-
0032865873
-
Regulation of dopaminergic activity in early Parkinson's disease
-
Tedroff J., Ekesbo A., Rydin E., Langstrom B., Hagberg G. Regulation of dopaminergic activity in early Parkinson's disease. Ann. Neurol. 46:1999;359-365
-
(1999)
Ann. Neurol.
, vol.46
, pp. 359-365
-
-
Tedroff, J.1
Ekesbo, A.2
Rydin, E.3
Langstrom, B.4
Hagberg, G.5
-
21
-
-
0035889677
-
Cholinergic neuronal modulations affect striatal dopamine transporter activity: PET studies in the conscious monkey brain
-
Tsukada H., Nishiyama S., Ohba H., Sato K., Harada N., Kakiuchi T. Cholinergic neuronal modulations affect striatal dopamine transporter activity: PET studies in the conscious monkey brain. Synapse. 42:2001;193-195
-
(2001)
Synapse
, vol.42
, pp. 193-195
-
-
Tsukada, H.1
Nishiyama, S.2
Ohba, H.3
Sato, K.4
Harada, N.5
Kakiuchi, T.6
-
22
-
-
0029558914
-
The vesicular monoamine transporter is not regulated by dopaminergic drug treatments
-
Vander Borght T.M., Kilbourn M.R., Desmond T.J., Kuhl D.E., Frey K.A. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur. J. Pharmacol. 294:1995;77-583
-
(1995)
Eur. J. Pharmacol.
, vol.294
, pp. 77-583
-
-
Vander Borght, T.M.1
Kilbourn, M.R.2
Desmond, T.J.3
Kuhl, D.E.4
Frey, K.A.5
-
23
-
-
0037318137
-
Interaction of isoflurane with the dopamine transporter
-
Votaw J., Byas-Smith M., Hua J., Voll R., Martarello L., Levey A.I., Bowman F.D., Goodman M. Interaction of isoflurane with the dopamine transporter. Anesthesiology. 98:2003;404-411
-
(2003)
Anesthesiology
, vol.98
, pp. 404-411
-
-
Votaw, J.1
Byas-Smith, M.2
Hua, J.3
Voll, R.4
Martarello, L.5
Levey, A.I.6
Bowman, F.D.7
Goodman, M.8
-
24
-
-
0035673504
-
Chronic and acute regulation of Na+/Cl-dependent neurotransmitter transporters: Drugs, substrates, presynaptic receptors, and signaling systems
-
Zahniser N.R., Doolen S. Chronic and acute regulation of Na+/Cl-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92:2001;21-55
-
(2001)
Pharmacol. Ther.
, vol.92
, pp. 21-55
-
-
Zahniser, N.R.1
Doolen, S.2
|